China Pharma Holdings, Inc.

CPHIAMEXUSD
1.10 USD
0.49 (78.89%)AT CLOSE (11:59 AM EDT)
1.48
0.38 (34.09%)
POST MARKET (AS OF 04:26 PM EDT)
Post Market
AS OF 04:26 PM EDT
1.48
0.38 (34.09%)
🟢Market: OPEN

China Pharma Holdings, Inc. (CPHI) trades at $1.48 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, CPHI trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 14, 2026.

Open?$0.60
High?$1.60
Low?$0.57
Prev. Close?$0.61
Volume?73.4M
Avg. Volume?1.3M
VWAP?$1.23
Rel. Volume?58.35x
Bid / Ask
Bid?$1.29 × 100
Ask?$1.29 × 2.2K
Spread?$0.00
Midpoint?$1.29
Valuation & Ratios
Market Cap?24.7M
Shares Out?40.5M
Float?2.0M
Float %?4.8%
P/E Ratio?N/A
P/B Ratio?0.67
EPS?-$0.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Employees
221
Market Cap
24.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2002-04-14
Address
2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE, F4 570216
Phone: 8689866811730
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
3
Momentum?
17
Short Sent.?
80
Piotroski F-Score?2/9Weak
Altman Z-Score?0.01Distress
Confidence?47%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.25%Low
Short Interest?24.5K
Days to Cover?1.0
Free Float2.0M
Avg Daily Volume42.3K
Settlement Date2026-06-30
Financial Health
Current Ratio?0.28Weak
Quick Ratio?0.07Weak
Cash Ratio?0.02Low
Debt/Equity?0.09Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.67CHEAP
P/S?
Peers
100
S&P
21
6.19FAIR
P/FCF?
Peers
100
S&P
3
165.0PRICEY
EV/EBITDA?
S&P
97
-19.4CHEAP
EV/Sales?
Peers
100
S&P
20
7.00HIGH
Returns & Efficiency
ROE?
S&P
9
-9.6%WEAK
ROA?
S&P
3
-7.9%WEAK
Cash Flow & Enterprise
FCF?$149.8K
Enterprise Value?$27.9M
Fundamentals ratios updated end of day